Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
PHAXIAM Therapeutics S.A.
E
EURONEXT:PHXM
Euronext
- -
EUR
- -
- -
ISIN
FR001400K4B1
Return %
Stock
S&P 500
1Y
- -
14.39
3Y
- -
81.42
5Y
- -
68.62
Use logarithmic scale
Customize view
EUR
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
3.55
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-3.62
-16.06
-13.94
-19.94
-25.37
-17.28
-19.7
-32.29
-33.78
-20.99
-0.07
-0.07
Free Cash Flow per Basic Share
0.95
-13.61
-12.06
-19.72
-22.42
-13.6
-27.56
-32.69
-24.36
-22.26
-9.49
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-3.1
-14.98
-12.86
-18.89
-24.36
-16.35
-18.77
-31.36
-32.86
-19.78
0.86
0.86
Tangible Book Value per Share
-6.77
26.77
56.31
62.53
41.19
93.45
74.19
43.77
11.96
8.91
7
7
Basic Weighted Avg Shares
1
1
1
1
1
2
2
2
2
3
3
3
Sales/Revenue/Turnover
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
-393.13
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
1
1
4
5
5
3
- -
Net Income, GAAP
-2
-8
-9
-15
-22
-34
-38
-63
-73
-54
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
177.82
177.82
Profit Margin (%)
- -
-451.92
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
2
14
35
46
36
180
129
62
20
20
31
31
LT Debt
6
1
- -
- -
3
2
1
13
24
23
10
10
Total Equity
-4
14
36
47
36
181
146
86
27
23
23
23
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
47.48
49.55
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
10.73
10.73
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Structure
EUR
•
in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
1
- -
3
LT Borrowings
- -
- -
8
LT Finance Leases
3
- -
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
- -
3
Market Capitalization
35
17
11
Working Capital
EUR
•
in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
62
- -
43
Cash, Cash Equivalents & STI
54
- -
39
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
28
- -
12
Payables & Accruals
12
- -
5
ST Debt
1
- -
3
Deferred Revenue
- -
- -
- -
Growth Rates
EUR
•
in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Total Equity
0.14%
-28.21%
2.81%
Free Cash Flow
-107.31%
13.68%
-44.19%
Net Income, GAAP
42.09%
-6.26%
-99.58%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -
Quarterly Revenue
EUR
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Quarterly Earnings Per Share
EUR
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
-5.11
- -
- -
- -
-20.99
2022
-3.55
- -
- -
- -
-0.07
2023
- -
- -
- -
- -
- -
Quarterly Dividends Per Share
EUR
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Company Description
Company Profile API
ChatGPT
Google Sheets
Address
Similar Companies
Business
Toronto
London
Frankfurt
Dubai
Mumbai
Hong Kong
Seoul
Tokyo
Unlock non-US companies
Get Access
Already premium?
Sign in
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Stock Prices API
ChatGPT
Google Sheets